Biocon - Global Healthcare Company
About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
  About Us
  Research & Development
  Branded Formulations
  Financial Results
  - Concall Invite Q1 FY15
  - Annual Report 2014
  - Annual General Meeting 2014
  - Investor Presentation
  Facilities Virtual Tour
  - Biocon
  - Syngene
  - Clinigene
  - Biocon Profile
  - CMD Profile
  - Video Gallery

Annual General
Meeting 2014

for more details, please visit:

Write to:

  Biocon is an emerging global biopharmaceutical enterprise

focused on delivering affordable innovation. It is committed to

reduce therapy costs of chronic diseases like diabetes, cancer

and autoimmune diseases by leveraging India's cost advantage

to deliver affordable healthcare solutions to patients, partners

and healthcare systems across the globe.

Q4 & FY 2014: Key Highlights
Q4FY14 Results
Stock Update
  Latest Press Release

Jun 23, 2014
Kiran Mazumdar-Shaw Awarded the '2014 Global Economy Prize' by the Kiel Institute for the World Economy...

  Media Coverage

June 04, 2014
Financial Express:
Biocon arm, Bristol-Myers Squibb extend drug discovery partnership...

June 04, 2014
Biocon, Bristol-Myers Squibb extend partnership...


Biocon Foundation

Arogya Raksha Yojana

Biocon Malaysia


          Patient Contact

          Patient Contact




Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Clinigene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer | Authorised Users               © 2014, Biocon. All Rights Reserved